Literature DB >> 27869379

Rosacea Management: Update on general measures and topical treatment options.

M Schaller1, H Schöfer2, B Homey3, M Hofmann4, U Gieler5, P Lehmann6, T A Luger7, T Ruzicka8, M Steinhoff9.   

Abstract

Although there is presently no cure for rosacea, there are several recommended treatment options available to control many of the symptoms and to prevent them from getting worse. In addition to self-help measures like avoidance of trigger factors and proper skin care, rosacea management should include topical medications as one of the first-line choices for patients with erythematous and mild to severe papulopustular rosacea. Since mixed forms of characteristic rosacea symptoms are more common, medical treatment must be symptom-tailored for each individual case and will often involve a combination therapy. Approved topical agents for the major symptoms of rosacea encompass brimonidine for erythema and ivermectin, metronidazole or azelaic acid for inflammatory lesions, all of which have shown their efficacy in numerous valid, well-controlled trials. In addition, there are several other, not approved topical treatments which are possible options that require further validation in larger well-controlled studies.
© 2016 Deutsche Dermatologische Gesellschaft (DDG). Published by John Wiley & Sons Ltd.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27869379     DOI: 10.1111/ddg.13143

Source DB:  PubMed          Journal:  J Dtsch Dermatol Ges        ISSN: 1610-0379            Impact factor:   5.584


  5 in total

1.  [Granulomatous rosacea in a lung transplant recipient : A possible therapy option in a unique group of patients].

Authors:  Claudia Ansorge; Kristin Technau-Hafsi
Journal:  Hautarzt       Date:  2020-02       Impact factor: 0.751

2.  Open-label Extension Study Evaluating Long-term Safety and Efficacy of FMX103 1.5% Minocycline Topical Foam for the Treatment of Moderate-to-Severe Papulopustular Rosacea.

Authors:  Linda Stein Gold; James Q Del Rosso; Leon Kircik; Neal D Bhatia; Deirdre Hooper; Walter Nahm; Iain Stuart
Journal:  J Clin Aesthet Dermatol       Date:  2020-11-01

3.  Safety and Pharmacokinetics of FMX103 (1.5% Minocycline Topical Foam) in Subjects with Moderate-to-Severe Papulopustular Rosacea under Maximum-use Treatment Conditions.

Authors:  Terry M Jones; Iain Stuart
Journal:  J Clin Aesthet Dermatol       Date:  2021-03-01

Review 4.  Managing Rosacea in the Clinic: From Pathophysiology to Treatment-A Review of the Literature.

Authors:  Sandra Marchese Johnson; Andrew Berg; Chelsea Barr
Journal:  J Clin Aesthet Dermatol       Date:  2020-04-01

Review 5.  Recent advances in understanding and managing rosacea.

Authors:  Joerg Buddenkotte; Martin Steinhoff
Journal:  F1000Res       Date:  2018-12-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.